These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26996159)

  • 1. Classification of Gemcitabine resistant Cholangiocarcinoma cell lines using synchrotron FTIR microspectroscopy.
    Wongwattanakul M; Hahnvajanawong C; Tippayawat P; Chio-Srichan S; Leelayuwat C; Limpaiboon T; Jearanaikoon P; Heraud P
    J Biophotonics; 2017 Mar; 10(3):367-376. PubMed ID: 26996159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring the Progression of Liver Fluke-Induced Cholangiocarcinoma in a Hamster Model Using Synchrotron FTIR Microspectroscopy and Focal Plane Array Infrared Imaging.
    Chatchawal P; Wongwattanakul M; Tippayawat P; Jearanaikoon N; Jumniansong A; Boonmars T; Jearanaikoon P; Wood BR
    Anal Chem; 2020 Dec; 92(23):15361-15369. PubMed ID: 33170647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchrotron FTIR microspectroscopy revealed apoptosis-induced biomolecular changes of cholangiocarcinoma cells treated with ursolic acid.
    Maphanao P; Thanan R; Loilome W; Chio-Srichan S; Wongwattanakul M; Sakonsinsiri C
    Biochim Biophys Acta Gen Subj; 2020 Dec; 1864(12):129708. PubMed ID: 32810561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of gemcitabine-sensitive/resistant cancer cells by cell cloning and synchrotron FTIR microspectroscopy.
    Rutter AV; Siddique MR; Filik J; Sandt C; Dumas P; Cinque G; Sockalingum GD; Yang Y; Sulé-Suso J
    Cytometry A; 2014 Aug; 85(8):688-97. PubMed ID: 24845779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced expression of ten-eleven translocation 1 reverses gemcitabine resistance in cholangiocarcinoma accompanied by a reduction in P-glycoprotein expression.
    Wang C; Ye H; Zhang L; Cheng Y; Xu S; Zhang P; Zhang Z; Bai J; Meng F; Zhong L; Shi G; Li H
    Cancer Med; 2019 Mar; 8(3):990-1003. PubMed ID: 30784212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemcitabine enhances cytotoxic activity of effector T-lymphocytes against chemo-resistant cholangiocarcinoma cells.
    Sawasdee N; Thepmalee C; Sujjitjoon J; Yongpitakwattana P; Junking M; Poungvarin N; Yenchitsomanus PT; Panya A
    Int Immunopharmacol; 2020 Jan; 78():106006. PubMed ID: 31780372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin Augments Gemcitabine-Mediated Anti-Cancer Effects by Inhibiting Yes-Associated Protein in Human Cholangiocarcinoma Cells.
    Kitagawa K; Moriya K; Kaji K; Saikawa S; Sato S; Nishimura N; Namisaki T; Akahane T; Mitoro A; Yoshiji H
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin synergistically enhances the efficacy of gemcitabine against gemcitabine-resistant cholangiocarcinoma via the targeting LAT2/glutamine pathway.
    Thongpon P; Intuyod K; Chomwong S; Pongking T; Klungsaeng S; Muisuk K; Charoenram N; Sitthirach C; Thanan R; Pinlaor P; Pinlaor S
    Sci Rep; 2024 Jul; 14(1):16059. PubMed ID: 38992159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the Anti-Cancer Potency of Sulfated Galactans on Cholangiocarcinoma Cells Using Synchrotron FTIR Microspectroscopy, Molecular Docking, and In Vitro Studies.
    Boonsri B; Choowongkomon K; Kuaprasert B; Thitiphatphuvanon T; Supradit K; Sayinta A; Duangdara J; Rudtanatip T; Wongprasert K
    Mar Drugs; 2021 Apr; 19(5):. PubMed ID: 33946151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of NAD(P)H-quinone oxidoreductase 1 enhanced the susceptibility of cholangiocarcinoma cells to chemotherapeutic agents.
    Zeekpudsa P; Kukongviriyapan V; Senggunprai L; Sripa B; Prawan A
    J Exp Clin Cancer Res; 2014 Jan; 33(1):11. PubMed ID: 24460787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells.
    Buranrat B; Prawan A; Kukongviriyapan U; Kongpetch S; Kukongviriyapan V
    World J Gastroenterol; 2010 May; 16(19):2362-70. PubMed ID: 20480521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines.
    Tepsiri N; Chaturat L; Sripa B; Namwat W; Wongkham S; Bhudhisawasdi V; Tassaneeyakul W
    World J Gastroenterol; 2005 May; 11(18):2748-53. PubMed ID: 15884115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles.
    Sitthirak S; Suksawat M; Phetcharaburanin J; Wangwiwatsin A; Klanrit P; Namwat N; Khuntikeo N; Titapun A; Jarearnrat A; Sangkhamanon S; Loilome W
    PeerJ; 2022; 10():e13876. PubMed ID: 35990899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs.
    Yang R; Wang D; Han S; Gu Y; Li Z; Deng L; Yin A; Gao Y; Li X; Yu Y; Wang X
    Int J Biol Sci; 2022; 18(1):43-64. PubMed ID: 34975317
    [No Abstract]   [Full Text] [Related]  

  • 15. Long non-coding RNA LINC00665 promotes gemcitabine resistance of Cholangiocarcinoma cells via regulating EMT and stemness properties through miR-424-5p/BCL9L axis.
    Lu M; Qin X; Zhou Y; Li G; Liu Z; Geng X; Yue H
    Cell Death Dis; 2021 Jan; 12(1):72. PubMed ID: 33436545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Upregulation of OCT4 in Acidic Extracellular pH is Associated with Gemcitabine Resistance in Cholangiocarcinoma Cell Lines.
    Choodetwattana P; Proungvitaya S; Jearanaikoon P; Limpaiboon T
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2745-2748. PubMed ID: 31554372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two Recombinant Bacteriocins, Rhamnosin and Lysostaphin, Show Synergistic Anticancer Activity Against Gemcitabine-Resistant Cholangiocarcinoma Cell Lines.
    Kerdkumthong K; Chanket W; Runsaeng P; Nanarong S; Songsurin K; Tantimetta P; Angsuthanasombat C; Aroonkesorn A; Obchoei S
    Probiotics Antimicrob Proteins; 2024 Jun; 16(3):713-725. PubMed ID: 37294416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression analysis for predicting gemcitabine resistance in human cholangiocarcinoma.
    Sato J; Kimura T; Saito T; Anazawa T; Kenjo A; Sato Y; Tsuchiya T; Gotoh M
    J Hepatobiliary Pancreat Sci; 2011 Sep; 18(5):700-11. PubMed ID: 21451941
    [TBL] [Abstract][Full Text] [Related]  

  • 19.  Thymosin β10 as a predictive biomarker of response to 5-fluorouracil chemotherapy in cholangiocarcinoma.
    Sribenja S; Natthasirikul N; Vaeteewoottacharn K; Sawanyawisuth K; Wongkham C; Jearanaikoon P; Wongkham S
    Ann Hepatol; 2016; 15(4):577-85. PubMed ID: 27236157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT/mTOR and EMT signaling pathways.
    Jaidee R; Kukongviriyapan V; Senggunprai L; Prawan A; Jusakul A; Laphanuwat P; Kongpetch S
    Life Sci; 2022 May; 296():120427. PubMed ID: 35218764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.